Gerard Brophy, EVP, Biopharma Production at Avantor, Inc. (AVTR), sold 8,161 shares at $33.79 ($279K) on 2022-02-23, disclosed to the SEC on 2022-02-25.
Open-market sale of $279k AVTR by EVP, Biopharma Production. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.79 | 3,059 | $103K | 37.0% |
| 2 | $33.79 | 3,059 | $103K | 37.0% |
| 3 | $35.39 | 2,043 | $72K | 25.9% |
| Total | $34.19 avg | 8,161 | $279K | 100% |
| Filing → |
| AVTR | SELL | 2023-02-02 | $568K | — | Filing → |
| AVTR | SELL | 2022-05-23 | $1.2M | — | Filing → |
| AVTR | SELL | 2022-03-02 | $140K | — | Filing → |